Internal Medicine, Infectious Disease · Portland, OR
NPI
1104143726
Since 2010
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3550 N Interstate Ave, Interstate Medical Office Building
Portland, OR, 97227
Phone (503) 249-3442
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
1,210 services
Medicare patients, 2024
349
Average age 70
Drug cost, 2024
$3.9M
2,328 prescriptions
Company payments, 2025
$144
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter A Leahey was code G0008 (administration of influenza virus vaccine), 314 times for 314 patients. In total Peter A Leahey billed 1,210 services in 12 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| G0008 Administration of influenza virus vaccine | Office | 314 | 314 | $19.19 | $6,025 |
| 90480 Vaccine Administration | Office | 279 | 279 | $43.67 | $12K |
| 91320 Vaccine Product | Office | 279 | 279 | $152.78 | $43K |
| 90662 Vaccine Product | Office | 252 | 252 | $72.52 | $18K |
| 90656 Vaccine Product | Office | 62 | 62 | $21.90 | $1,358 |
By year: 2022 $2,012 for 105 services; 2023 $2,528 for 38 services; 2024 $82K for 1,210 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter A Leahey prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 150 prescriptions and refills. In total Peter A Leahey wrote 2,328 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 150 | 438 | 42 | $1.6M |
| Atorvastatin Calcium Generic | 144 | 386 | 42 | $1,486 |
| Valacyclovir Valacyclovir Hcl | 80 | 214 | 26 | $3,506 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 68 | 195 | 18 | $645K |
| Lisinopril Generic | 67 | 201 | 21 | $743 |
| Tivicay Dolutegravir Sodium | 66 | 180 | 20 | $450K |
| Gabapentin Generic | 57 | 99 | 13 | $1,385 |
| Tamsulosin Hcl Generic | 56 | 154 | 16 | $843 |
| Amlodipine Besylate Generic | 51 | 151 | 14 | $562 |
| Abacavir-Lamivudine Abacavir Sulfate/Lamivudine | 45 | 135 | 14 | $5,253 |
| Descovy Emtricitabine/Tenofov Alafenam | 43 | 118 | 13 | $247K |
| Cefadroxil Generic | 38 | 98 | 12 | $3,014 |
| Doxycycline Monohydrate Generic | 37 | 55 | Under 11 | $1,004 |
| Trazodone Hcl Generic | 37 | 77 | Under 11 | $490 |
| Pravastatin Sodium Generic | 35 | 105 | 11 | $700 |
Brand drugs: 570 claims; generic drugs: 1,737 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter A Leahey $144 ($144 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $144.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 2 | $144 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.